Comments
Loading...

ProShares Ultra Nasdaq Biotechnology

BIBNASDAQ
Logo brought to you by Benzinga Data

As of Feb 28, 2025

Number of Stock Holdings
264
Number of Bond Holdings
1
Total Holdings
274
Number of ETFs
-

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB), Top Holdings

ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB)

TickerNameShare %
GILDGilead Sciences Inc5.60%
REGNRegeneron Pharmaceuticals, Inc.5.21%
VRTXVertex Pharmaceuticals Inc6.23%
AMGNAmgen Inc6.62%

FAQ

Q

How has BIB ETF performed?

A

The BIB ETF is currently trading at $53.99, which represents a 3.25% change. Over the past 52 weeks, the ETF has traded as high as $69.56 and as low as $47.20.

Q

What is the expense ratio for BIB?

A

The expense ratio of BIB is 0.95%. This represents the annual fee that all funds or ETFs charge their shareholders.

Q

What is the Assets Under Management (AUM) for BIB?

A

The total Assets Under Management (AUM) for BIB is 60.83M. This represents the total market value of the assets managed by the ETF.

Q

What is the investment style for BIB?

A

BIB follows a Trading-Leveraged Equity investment style.

Q

What are the top holdings for BIB?

A

The top holdings of BIB include: GILD (5.6%), REGN (5.21%), VRTX (6.23%), AMGN (6.62%). These represent the largest positions in the ETF's portfolio.

Q

What is the average daily trading volume for BIB?

A

Average daily volume data for BIB is currently not available.